US Patent Applications in Skin Care Formulation Published in 2013
LIST OF US PROVISIONAL PATENT APPLICATIONS IN SKIN CARE PUBLISHED IN 2013
This list includes Provisional Patent Applications published in the United States. The list was retrieved by using a refined search strategy on the claims section of all patent applications.
Salient search terms included formulations and compositions in skin, lip and eye care including creams, lotions, toners, pomades, antiwrinkle and antiaging products, nutraceuticals as
well as ingredients derived from nature, biotechnology and nanotechnology to deliver emolliency, humectancy, distinct sensory properties, antioxidant and free radicals protection, etc.

Thank you for visiting FormulaScan . Please click on the Patent No to study the full patent document

US PATENT APLICATIONS IN SKIN CARE FORMULATION PUBLISHED IN 2013



Application No.: US20130004542A1  Published: 03/Jan/2013

Title: COMPOSITION

Applicant/Assignee:

Application No.: 13/501303   Filing Date: 21/Oct/2010

Abstract:

The invention provides a composition for inhalation comprising a pharmaceutically acceptable glassy matrix and at least one bioactive material within the matrix, wherein the glassy matrix comprises a metal ion salt, wherein the composition is substantially free of polyols and is in the form of a powder and wherein the powder comprises particles having a median geometric diameter of less than 10 [mu]m.

Priority: GB20090018450 Applic. Date: 2009-10-21; WO2010GB01955 Applic. Date: 2010-10-21

Inventor: MARTYN GLEN [GB]


Application No.: US20130004546A1  Published: 03/Jan/2013

Title: HYDROGEL OF MICROSPHERES

Applicant/Assignee: BIOPHARMEX HOLDING LIMITED

Application No.: 13/522773   Filing Date: 20/Jan/2011

Abstract:

The invention relates to an injectable composition intended for tissue induction of the soft tissues by a system of immediate and prolonged progressive release. In particular, the invention relates to a composition comprising a gel of at least one first biodegradable polymer forming a first agent for filling soft tissues in an animal, and a suspension in this gel of microspheres with an average diameter between 5 and 50 micrometres, said microspheres comprising 50 to 90 wt. % of at least one biodegradable polysaccharide relative to the total weight of the microspheres, said microspheres inducing a second filling by tissue induction and containing at least one second biodegradable polymer forming at least one third filling of the soft tissues in an animal.

Priority: FR20100050355 Applic. Date: 2010-01-20; US2010-303094P Applic. Date: 2010-02-10; WO2011EP50727 Applic. Date: 2011-01-20

Inventor: LAUGIER ELIZABETH [CH]


Application No.: US20130011451A1  Published: 10/Jan/2013

Title: FOOTBED WITH NON-DENATURED COLLAGEN

Applicant/Assignee: DIVERSIFIED GLOGAL TECHNOLOGIES, LLC

Application No.: 13/176841   Filing Date: 06/Jul/2011

Abstract:

The invention relates to a composition comprised of a prepolymer, at least one additive, and non-denatured collagen fibers and a method of making the same. The composition of the instant invention is for use as a footbed to augment the shock absorption already provided to the human body via a shoe and the collagenous, fatty pad of the human foot.

Priority:

Inventor: CELIA WAYNE [US]


Application No.: US20130011483A1  Published: 10/Jan/2013

Title: FORMULATIONS OF MAZINDOL

Applicant/Assignee: SUPERNUS PHARMACEUTICALS, INC

Application No.: 13/638294   Filing Date: 30/Mar/2011

Abstract:

Formulations of mazindol having superior stability and methods of administering same are provided. The formulations may be immediate, enhanced, or otherwise delayed release formulations of mazindol.

Priority: US2010-282788P Applic. Date: 2010-03-31; WO2011US30442 Applic. Date: 2011-03-30

Inventor: KIDANE ARGAW [US]; BHATT PADMANABH P [US]


Application No.: US20130017230A1  Published: 17/Jan/2013

Title: JELLY-FORM PREPARATION AND METHOD FOR PRODUCING JELLY-FORM PREPARATION

Applicant/Assignee: NITTO DENKO CORPORATION

Application No.: 13/546580   Filing Date: 11/Jul/2012

Abstract:

Provided is a jelly preparation which enables easy intraoral dissolution thereof, easy adjustment of the dissolution time, and stable containment of a drug therein. The jelly preparation of the present invention is a jelly preparation including water, a gelatin, a drug, and a trivalent metal ion.

Priority: JP20110154897 Applic. Date: 2011-07-13

Inventor: SHISHIDO TAKUYA [JP]; ASARI DAISUKE [JP]; HORI MITSUHIKO [JP]


Application No.: US20130022643A1  Published: 24/Jan/2013

Title: Antimicrobial Anti-chafing Chelated Silver Oxide Compound

Applicant/Assignee: BODYGLIDE

Application No.: 13/188630   Filing Date: 22/Jul/2011

Abstract:

Described herewithin is a composition comprising an anti-chafing balm with C18-36 acid triglycerides, capric/carprylic triglycerides, and tribehinin together with a chelated silver oxide complex comprising a barrier film when applied to the skin. The film is a dual purpose antibacterial and anti-chafing barrier topically applied to human skin, providing a layer of chelated silver oxide complex further comprised of a dermatologically acceptable carrier, with friction (chafe) reducing properties, selected from the group consisting of organic solutions, gels, liquids, balms, aerosols, emulsifiers, lotions, water-in-oil emulsions, oil-in-water emulsions, surfactants, aloe barbedensis leaf juice and tocopherol acetate.

Priority:

Inventor: STERNOFF WILLIAM R [US]; WINGFIELD WILLIAM [US]; REED FRANK [US]


Application No.: US20130022644A1  Published: 24/Jan/2013

Title: NOVEL N-PHENYLACETAMIDE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

Applicant/Assignee: GALDERMA RESEACH & DEVELOPMENT

Application No.: 13/202699   Filing Date: 26/Feb/2010

Abstract:

Compounds of general Formula (I), and cosmetic and pharmaceutical compositions including such a compound are described.

Priority: FR20090053754 Applic. Date: 2009-06-05; US2009-202417P Applic. Date: 2009-02-26; WO2010EP52497 Applic. Date: 2010-02-26

Inventor: PASCAL JEAN-CLAUDE [FR]; POINSARD CEDRIC [FR]


Application No.: US20130022671A1  Published: 24/Jan/2013

Title: CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR

Applicant/Assignee:

Application No.: 13/551526   Filing Date: 17/Jul/2012

Abstract:

Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.

Priority: GB20090005567 Applic. Date: 2009-03-31; US2009-456443 Applic. Date: 2009-06-16; US2008-132429P Applic. Date: 2008-06-16; US2009-209056P Applic. Date: 2009-03-02

Inventor: GLIDDEN PAUL F [US]; PILGRIM ALISON J [US]; HANSON STEPHEN R [US]


Application No.: US20130039952A1  Published: 14/Feb/2013

Title: CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS

Applicant/Assignee: LEO PHARMA A/S

Application No.: 13/518214   Filing Date: 22/Dec/2010

Abstract:

Calcipotriol monohydrate nanocrystals prepared by the process disclosed herein may be incorporated in a pharmaceutical composition for use in the prevention or treatment of dermal diseases and conditions.

Priority: WO2009DK00267 Applic. Date: 2009-12-22; US2010-293091P Applic. Date: 2010-01-07; WO2010DK00183 Applic. Date: 2010-12-22

Inventor: PETERSSON KARSTEN [DK]


Application No.: US20130045238A1  Published: 21/Feb/2013

Title: EMULSIONS FOR TRANSDERMAL DELIVERY

Applicant/Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

Application No.: 13/265445   Filing Date: 22/Apr/2010

Abstract:

The present invention generally relates to transdermal delivery and, in particular, to transdermal delivery using nanoemulsions and other emulsions. In one aspect, the present invention is directed to emulsions comprising a first, continuous phase and a second, discontinuous phase. The first phase may be an aqueous liquid and the second phase may comprise a lipid, such as isopropyl myristate. In some cases, a surfactant, such as Pluronic TM L61, is used to stabilize the emulsion. Surprisingly, it has been found that such emulsions are effective at delivering pharmaceutically active agents, such as ciprofloxacin, when the formulation has a very low water content, for example, less than 30 wt % or less than 10 wt %. This is surprising because high water contents-not low water contents-are typically correlated with greater transdermal drug delivery, and thus, a low water content would have been considered to be unfavorable for facilitating transdermal drug delivery.

Priority: SG20090002734 Applic. Date: 2009-04-22; WO2010US01194 Applic. Date: 2010-04-22

Inventor: CHOW EDWIN PEI YONG [SG]; YING JACKIE Y [SG]; GAO SHU JUN [SG]


Application No.: US20130045248A1  Published: 21/Feb/2013

Title: PERSONAL CARE COMPOSITIONS COMPRISING AN ANTI-IRRITATION AGENT

Applicant/Assignee:

Application No.: 13/587206   Filing Date: 16/Aug/2012

Abstract:

A personal care composition comprising an anti-irritation agent such as a zinc pyrithione, a zinc salt or a combination thereof.

Priority: US201161524060P Applic. Date: 2011-08-16

Inventor: COFFINDAFFER TIMOTHY WOODROW [US]; HEATH BENJAMIN PARKER [US]; KEMP HELEN ROCHELLE [US]; WILLICUT ROBERT JOHN [US]; SCHWARTZ JAMES ROBERT [US]


Application No.: US20130052250A1  Published: 28/Feb/2013

Title: COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION

Applicant/Assignee: UNIVERSITY OF NEWCASTLE UPON TYNE

Application No.: 13/578228   Filing Date: 11/Feb/2011

Abstract:

The invention relates to compounds, compositions and methods for biofilm disruption and prevention. In particular, the invention relates to pharmaceutical compositions for the disruption of biofilm and prevention of biofilm in patients. The invention also relates to anti-biofouling compositions for the disruption of biofilm and prevention of biofilm on surfaces. The invention also relates to the removal of biological material from surfaces. The compositions of the invention include microbial deoxyribonucleases.

Priority: GB20100002396 Applic. Date: 2010-02-12; WO2011EP52062 Applic. Date: 2011-02-11

Inventor: BURGESS JAMES GRANT [GB]; HALL MICHAEL JOHN [GB]; NIJLAND REINDERT [NL]


Application No.: US20130052270A1  Published: 28/Feb/2013

Title: Use of Gold Nanoclusters in Ameliorating Oxidate Stress and/or Aging

Applicant/Assignee: CHUNG YUAN CHRISTIAN UNIVERSITY, MACKAY MEMORIAL HOSPITAL

Application No.: 13/218625   Filing Date: 26/Aug/2011

Abstract:

Disclosed herein is the novel use of a gold nanocluser for ameliorating oxidative stress and/or aging of a cultured cell or a subject having an oxidative stress and/or aging condition mediated by a vascular factor. The gold nanocluster has a particle size ranging from about 0.1 to 20 nm, and preferably is dihydrolipoic acid (DHLA) coated gold nanocluster.

Priority:

Inventor: YEH HUNG-I [TW]; CHANG WALTER H [TW]; LIN CHENG-AN [TW]; WANG HSUEH-HSIAO [TW]


Application No.: US20130052275A1  Published: 28/Feb/2013

Title: Warming Inch Loss Delivery System

Applicant/Assignee:

Application No.: 13/592285   Filing Date: 22/Aug/2012

Abstract:

This invention is a topical treatment for the skin, used for skin enhancement, firming, smoothing, refining and to reduce the appearance of cellulite

that has a self-warming or thermogenic effect comprised of a base combination of warming herbs (Ayurvedic), being any herbs that create a warming effect, combined with dietary minerals that can be blended together in any ratio.

Priority: US201161526897P Applic. Date: 2011-08-24

Inventor: WARD MICHELLE [US]


Application No.: US20130058985A1  Published: 07/Mar/2013

Title: Spray-Pumpable Composition Suitable for Topical Skin Application

Applicant/Assignee:

Application No.: 13/583520   Filing Date: 17/Mar/2011

Abstract:

The present invention relates to a spray-pumpable composition for topical use on the skin comprising hydrophilic silicon dioxide, an emulsifier, at least one active ingredient and optionally one or more additives. The present invention further relates to a method for the preparation of a spray-pumpable composition for topical use on the skin and the use of hydrophilic silicon dioxide for the preparation of suspensions in emulsions, in particular oil-in-water emulsions.

Priority: NL20102004437 Applic. Date: 2010-03-19; WO2011NL50186 Applic. Date: 2011-03-17

Inventor: WILLEMS MARIA MARGARETHA MARTINA [NL]; VAN DE LOCKAND PETRUS RICHARDUS MARINUS [NL]; STIFTSTRAAT PETER MEIJLINK [NL]


Application No.: US20130071439A1  Published: 21/Mar/2013

Title: METHODS AND COMPOSITIONS FOR TREATING BIOFILMS

Applicant/Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE

Application No.: 13/520745   Filing Date: 10/Jan/2011

Abstract:

Methods of treating or reducing biofilms, treating a biofilm-related disorder, and preventing biofilm formation using D-amino acids are described.

Priority: US2010-293414P Applic. Date: 2010-01-08; US2010-329930P Applic. Date: 2010-04-30; WO2011US20705 Applic. Date: 2011-01-10

Inventor: LOSICK RICHARD [US]; CLARDY JON [US]; KOLTER ROBERTO [US]; KOLODKIN-GAL ILLANA [US]; ROMERO DIEGO [US]; CAO SHUGENG [US]


Application No.: US20130089580A1  Published: 11/Apr/2013

Title: ALLOPLASTIC INJECTABLE DERMAL FILLER AND METHODS OF USE THEREOF

Applicant/Assignee:

Application No.: 13/695116   Filing Date: 29/Apr/2011

Abstract:

A composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent is provided. A method of making a composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent, said method comprising admixing a biocompatible and pliable material with a physiologically acceptable suspending agent, is also provided. A method of augmenting soft tissue to provide long-term reduction of a skin defect, said method comprising stimulating collagen beneath the skin defect is further provided. In an embodiment of the method of augmenting soft tissue, the stimulation of collagen production is effected by injecting into the deep reticular dermis an a dermal filler, said dermal filler being an alloplastic injectable suspension and comprising a biocompatible and pliable material and a physiologically acceptable suspending agent.

Priority: US2010-771524 Applic. Date: 2010-04-30; WO2011US34631 Applic. Date: 2011-04-29

Inventor: BOUTROS AYMAN [US]


Application No.: US20130089585A1  Published: 11/Apr/2013

Title: FILLER COMPRISING BEADS

Applicant/Assignee: MERZ PHARMA GMBH & CO., KGAA

Application No.: 13/639013   Filing Date: 07/Apr/2011

Abstract:

The present invention pertains to a filler comprising beads wherein said beads comprise a polyanionic biopolymer and divalent cations and wherein said polyanionic biopolymer is not alginate. Further, the present invention pertains to a process for manufacturing the claimed filler, and to an injection device comprising the filler.

Priority: EP20100003794 Applic. Date: 2010-04-08; US2010-321964P Applic. Date: 2010-04-08; WO2011EP01737 Applic. Date: 2011-04-07

Inventor: KIEHM KEVIN [DE]; HAUPTMEIER BERNHARD [DE]; BODERKE PETER [DE]


Application No.: US20130089605A1  Published: 11/Apr/2013

Title: Method for Preparation of Highly Pure Asiaticoside Composition from Centella Asiatica and a Method of Use Thereof

Applicant/Assignee: INDUS BIOTECH PRIVATE LIMITED

Application No.: 13/702834   Filing Date: 31/Aug/2010

Abstract:

Disclosed is a commercially viable asiaticoside composition having at least 99% purity that is derived from plant Centella asiatica and a manufacturing process thereof. Also disclosed is a method and the models for oral administration of therapeutically effective amounts of the asiaticoside composition for treatment of Inflammatory Bowel Diseases such as Ulcerative colitis, Crohn's disease and associated complications of inflammatory bowel diseases such as hemorrhoids, anal fissures, fistulas. Also disclosed is a method and model for oral administration of therapeutically effective amounts of the asiaticoside composition for treatment of Helicobacter Pylori, as well as a method and the models for oral administration of therapeutically effective amounts of the asiaticoside composition for prevention of colon cancer, gastric diseases and gastric carcinoma.

Priority: IN2010MU01760 Applic. Date: 2010-06-10; WO2010IN00575 Applic. Date: 2010-08-31

Inventor: SUNIL BHASKARAN [IN]; MOHAN VISHWARAMAN [IN]


Application No.: US20130095143A1  Published: 18/Apr/2013

Title: BIOMATERIAL FROM WHARTON'S JELLY UMBILICAL CORD

Applicant/Assignee: HISTOCELL, S.L

Application No.: 13/638535   Filing Date: 30/Mar/2010

Abstract:

The present invention relates to a biomaterial, specifically a hydrogel, based on the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans present exclusively in the Wharton's jelly of the umbilical cord (which can optionally be combined with cells as a combination therapy), and also to the methods for the production and use thereof.

Priority: WO2010EP02011 Applic. Date: 2010-03-30

Inventor: FONT PEREZ JULIO [ES]; CASTRO FEO MARIA BEGONA [ES]; DEL OLMO BASTERRECHEA MAITE [ES]


Application No.: US20130095151A1  Published: 18/Apr/2013

Title: BROAD SPECTRUM SUNSCREEN COMPOSITION COMPRISING 2 HYDROXY SULFOBETAINE OF CINNAMIDOALKYL AMINE

Applicant/Assignee: GALAXY SURFACTANTS LTD

Application No.: 13/704481   Filing Date: 17/Jun/2011

Abstract:

A photostable cosmetic composition for protection against UVA and UVB radiations of wavelengths between 280 and 400 nm, which comprises, in a cosmetically acceptable vehicle: (i) at least one UVA-sunscreen agents absorbing predominantly in the UVA-range

(ii) at least one UVB-sunscreen agents absorbing predominantly in the UVB-range

(iii) at least 0.1% by weight of a 2-hydroxy sulfobetaine of cinnamidoalkyl amine compound.

Priority: INMU29172009 Applic. Date: 2010-06-17; WO2011IB01371 Applic. Date: 2011-06-17

Inventor: JAWALE ARUN HARACHANDRA [IN]; JUMDE VAISHALI AMOL [IN]; DESAI ARCHANA KISHOR [IN]


Application No.: US20130095184A1  Published: 18/Apr/2013

Title: Metal-Containing Materials for Treatment of Bacterial Conditions

Applicant/Assignee: NUCRYST PHARMACEUTICALS CORP

Application No.: 12/109897   Filing Date: 25/Apr/2008

Abstract:

Metal-containing materials, as well as their preparation, formulations, and use are disclosed.

Priority: US2007-915604P Applic. Date: 2007-05-02; US2007-972501P Applic. Date: 2007-09-14; US2007-979239P Applic. Date: 2007-10-11

Inventor: LYCZAK JEFFREY B [US]; THOMPSON KATHERINE [US]; TURNER KATHERINE [US]; SCHECHTER PAUL [US]


Application No.: US20130096610A1  Published: 18/Apr/2013

Title: BIOPOLYMER MICROTHREADS WITH MICROSCALE SURFACE TOPOGRAPHIES

Applicant/Assignee:

Application No.: 13/635500   Filing Date: 17/Mar/2011

Abstract:

In one aspect, the invention features a textured microthread that includes or is fashioned from a naturally occurring polymer and that has a surface comprising micron-scale ridges with intervening grooves.

Priority: US2010-314829P Applic. Date: 2010-03-17; WO2011US28909 Applic. Date: 2011-03-17

Inventor: PINS GEORGE [US]; CAREY SHAWN [US]


Application No.: US20130101540A1  Published: 25/Apr/2013

Title: AQUEOUS DISPERSIONS OF POLYURETHANE AND NANOPARTICLES

Applicant/Assignee: BAYER MATERIALSCIENCE LLC

Application No.: 13/278274   Filing Date: 21/Oct/2011

Abstract:

The present disclosure is directed to aqueous dispersions comprising polyurethane and nanoparticles, and processes for preparing the aqueous dispersions. The dispersions comprise aqueous polyurethane dispersions having nanoparticles covalently incorporated into the polymer matrix. The dispersions are prepared by reacting isocyanate groups present on the polyurethane chain ends with free amine groups on a hydroxy- or amino-functionalized nanoparticle to covalently attach the polyurethane and the nanoparticle through urethane or urea linkages, respectively.

Priority:

Inventor: UNAL SERKAN [US]; BEREZKIN YULIYA [US]; SCHMITT PETER D [US]; HAIDER KARL W [US]; HUNT ROBERT N [US]


Application No.: US20130101650A1  Published: 25/Apr/2013

Title: USE OF DIHYDRODEHYDRODIISOEUGENOL AND PREPARATIONS COMPRISING DIHYDRODEHYDRODIISOEUGENOL

Applicant/Assignee: SYMRISE AG

Application No.: 13/639646   Filing Date: 08/Apr/2010

Abstract:

This invention relates to cosmetic and pharmaceutical preparations comprising (i) a diastereomer or a mixture of two or more diastereomers of the compound of formula (I) or (ii) a salt of a diastereomer or of a mixture of two or more diastereomers of the compound of formula (I) or (iii) a mixture of two or more salts of a diastereomer or of a mixture of two or more diastereomers of the compound of formula (I), a diastereomer, salt or a mixture as defined above as a drug for topical application and/or for the treatment of lipoatrophy

the non-therapeutic use of a diastereomer, salt or a mixture as defined above for the prevention, treatment or reduction of skin aging, especially skin wrinkles

the use of a diastereomer, salt or a mixture as defined above for the production of an orally administered non-pharmaceutical preparation.

Priority: WO2010EP54667 Applic. Date: 2010-04-08

Inventor: MEYER IMKE [DE]; KOCH OSKAR [DE]; KRUTMANN JEAN [DE]


Application No.: US20130115257A1  Published: 09/May/2013

Title: COMPOSITIONS AND METHODS FOR REMOVAL OR DESTRUCTION OF AMYLOID FIBRIL OR AMYLOID ADHESIN COMPRISING AGGREGATES

Applicant/Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN

Application No.: 13/808859   Filing Date: 08/Jul/2011

Abstract:

Methods and compositions for treating biofilms and diseases associated with amyloidosis such as Alzheimer's, Parkinson's and Huntington's disease, and Type 2 diabetes, by destroying amyloid fibrils in a two-step treatment are disclosed. The first step consists of binding to the amyloid fibril an intercalating molecule with a negatively charged group such as Congo red. The second step consists of adding metal ions, such as silver, gold(I), copper(I), palladium or lead ions or metal colloids of silver or gold, which destabilize the amyloid-dye complex. This process results in a disintegration of the fibril into peptide monomers and small aggregates of monomers.

Priority: GB20100011503 Applic. Date: 2010-07-08; GB20110003409 Applic. Date: 2011-03-01; WO2011BE00043 Applic. Date: 2011-07-08

Inventor: GYSEMANS MAARTEN [BE]; SNAUWAERT JOHAN [BE]; VAN HAESENDONCK CHRIS [BE]


Application No.: US20130122088A1  Published: 16/May/2013

Title: TABLET FORMULATIONS CONTAINING 8-[-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROM

Applicant/Assignee: OPKO HEALTH, INC

Application No.: 13/734432   Filing Date: 04/Jan/2013

Abstract:

Pharmaceutical formulations containing a salt of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, which are suitable for forming into a tablet dosage form, as well as tablet dosage forms are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.

Priority: US2009-531966 Applic. Date: 2009-12-15; WO2008US03653 Applic. Date: 2008-03-20; US2007-919501P Applic. Date: 2007-03-22

Inventor: QIU ZHIHUI [US]; CHO WING-KEE PHILIP [US]; ZHAO NA [US]; WONG VICTOR MING-SHE [US]


Application No.: US20130129661A1  Published: 23/May/2013

Title: MATERIAL FOR SKIN AND METHOD FOR PRODUCING MATERIAL FOR SKIN

Applicant/Assignee: TORAY INDUSTRIES, INC

Application No.: 13/582139   Filing Date: 01/Mar/2011

Abstract:

A material for skin is provided including a silicone component-containing polymer obtained by polymerizing a silicone monomer having a carbon-carbon double bond, and a component selected from an antibacterial agent and an alcohol. Provided are a material for skin, which is transparent and has a moderate moisture content, and also has high oxygen permeability, and a method for producing the same.

Priority: JP20100045038 Applic. Date: 2010-03-02; JP20100292169 Applic. Date: 2010-12-28; WO2011JP54583 Applic. Date: 2011-03-01

Inventor: KITAGAWA RUMIKO [JP]; NAKAMURA MASATAKA [JP]; KUSUDA SATOSHI [JP]


Application No.: US20130129789A1  Published: 23/May/2013

Title: ANTI-BACTERIAL APPLICATIONS OF POLY-N-ACETYLGLUCOSAMINE NANOFIBERS

Applicant/Assignee:

Application No.: 13/641015   Filing Date: 15/Apr/2011

Abstract:

Described herein are compositions comprising shortened fibers of poly-N-acetylglucosamine and/or a derivative thereof ("sNAG nanofibers") and anti-bacterial applications of such compositions. The sNAG nanofibers may be formulated into compositions for the prevention and/or treatment of bacterial infections and diseases associated with such infections. Regimens employing such compositions are also described.

Priority: US2010-324657P Applic. Date: 2010-04-15; WO2011US32709 Applic. Date: 2011-04-15

Inventor: VOURNAKIS JOHN N [US]; FINKIELSZTEIN SERGIO [US]


Application No.: US20130129797A1  Published: 23/May/2013

Title: POLYMERIC COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

Applicant/Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION

Application No.: 13/742877   Filing Date: 16/Jan/2013

Abstract:

Described herein are polymeric compositions that comprise at least one polymer residue and at least one crosslinking moiety, wherein the polymer residue is crosslinked by the crosslinking moiety and wherein the crosslinking moiety is formed from a reaction between a boronic acid moiety and a hydroxamic acid moiety. Also, described are methods of making and using such polymeric compositions.

Priority: US2009-226547 Applic. Date: 2009-06-18

Inventor: GUPTA KAVITA [US]; ROBERTS MEREDITH C [US]; KISER PATRICK F [US]; JAY JULIE I [US]


Application No.: US20130129801A1  Published: 23/May/2013

Title: AQUEOUS DISPERSION COMPRISING GALACTOLIPIDS AND METHOD FOR PRODUCTION THEREOF

Applicant/Assignee: SWEDISH OAT FIBER AB

Application No.: 13/699663   Filing Date: 24/May/2011

Abstract:

A method for preparing a dispersion of polar lipids in an ethanol-water mixture, the polar lipids including galactolipids. Anoil containing polar lipids including galactolipids is diluted using a first ethanol-water mixture having an ethanol concentration close to the critical polarity, wherein upon dilution the polar lipids form a lamellar liquid-crystalline phase, without first forming a hexagonal HII-phase. The invention also refers to an oil obtained by evaporating ethanol and water from the dispersion. The invention further refers to aqueous colloidal dispersions of polar lipids including galactolipids, to an oil containing polar lipids including galactolipids and to pharmaceutical, cosmetic and food compositions including such dispersions and/or oil.

Priority: SE20100050515 Applic. Date: 2010-05-24; US2010-347643P Applic. Date: 2010-05-24; WO2011SE50646 Applic. Date: 2011-05-24

Inventor: LARSSON KARE [SE]; HARROD MAGNUS [SE]


Application No.: US20130142849A1  Published: 06/Jun/2013

Title: CONTROLLED RELEASE FORMULATIONS OF DRONEDARONE

Applicant/Assignee: LUPIN LIMITED

Application No.: 13/817169   Filing Date: 13/Aug/2011

Abstract:

The present invention relates to controlled release formulation of dronedarone or pharmaceutically acceptable salts, esters, metabolites, prodrugs or enantiomers thereof and controlled release polymers. The use of controlled release formulations of Dronedarone would improve the bioavailability and the patient compliance with reduction in number of dosages to be taken per day.

Priority: IN2010KO00924 Applic. Date: 2010-08-17; WO2011IB01882 Applic. Date: 2011-08-13

Inventor: DESHMUKH ASHISH ASHOKRAO [IN]; BHUTADA PRAVIN MEGHRAJJI [IN]; CHANDRAN SAJEEV [IN]; KULKARNI SHIRISH [IN]


Application No.: US20130142851A1  Published: 06/Jun/2013

Title: Compositions Comprising Components Coated With a Liquid Impermeable but Gas Permeable Layer, Use Thereof for Treating Cutaneous and Other Exocrine Gland Diseases

Applicant/Assignee:

Application No.: 13/750626   Filing Date: 25/Jan/2013

Abstract:

The present invention relates to medically efficacious agents coated with substance that forms a liquid impermeable but gas permeable layer, the treatment of medical conditions therewith, and particularly medical conditions at least partially characterised by blockage or other malfunction of ducts of exocrine glands and especially ducts of sweat glands.

Priority: GB20030016940 Applic. Date: 2003-07-19; GB20030027006 Applic. Date: 2003-11-20; US2004-595033 Applic. Date: 2004-07-19; WO2004GB03104 Applic. Date: 2004-07-19

Inventor: WARD WARREN [GB]


Application No.: US20130142884A1  Published: 06/Jun/2013

Title: Cream for Applying on a Body

Applicant/Assignee: D & Y LABORATORIES, D&Y LABORATORIES

Application No.: 13/751796   Filing Date: 28/Jan/2013

Abstract:

A cream has at least two components, one of the components includes stable water clusters, and the cream is applied on a body to produce local surface effects, local deep effects, and non-local effects in the body.

Priority: US2009-592877 Applic. Date: 2009-12-03; US201261611981P Applic. Date: 2012-03-16

Inventor: LO SHUI YIN [US]; GANN DAVID L [US]; GANN MARTINE [US]


Application No.: US20130149348A1  Published: 13/Jun/2013

Title: HYDROXYAPATITE TISSUE FILLER AND ITS PREPARATION AND USE

Applicant/Assignee: CAM BIOCERAMICS B.V

Application No.: 13/684912   Filing Date: 26/Nov/2012

Abstract:

The invention pertains to a biocompatible composition, suitable for use in soft or hard tissue augmentation, wherein the composition is an aqueous suspension containing a carrier fraction of ceramic particles of less than 15 mum and an augmentation fraction of ceramic particles of at least 20 mum. The ceramics typically include calcium phosphate. The composition is a may be used in soft tissue repair as well as hard bone replacement. It advantageously avoids the need for foreign body materials which are conventionally applied to stabilize augmentation suspensions.

Priority: EP20060121834 Applic. Date: 2006-10-05; US2009-444514 Applic. Date: 2009-06-03; WO2007NL50479 Applic. Date: 2007-10-04; US2006-849485P Applic. Date: 2006-10-05

Inventor: DE GROOT KLAAS [NL]; BEULING NIENKE [NL]; VAN DE MORTEL NOL [NL]; BEZEMER MARISKA [NL]


Application No.: US20130149356A1  Published: 13/Jun/2013

Title: Muscle-based grafts/implants

Applicant/Assignee: RTI BIOLOGICS, INC

Application No.: 13/815184   Filing Date: 07/Feb/2013

Abstract:

The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic agent to attract a desired cell.

Priority: US2010-807599 Applic. Date: 2010-09-09; US2007-949687 Applic. Date: 2007-12-03; US2006-480711 Applic. Date: 2006-07-03; US2004-793976 Applic. Date: 2004-03-05; US2004-754310 Applic. Date: 2004-01-09

Inventor: MILLS C RANDAL [US]; BIANCHI JOHN R [US]; ROBERTS MICHAEL R [US]; CHEUNG DAVID T [US]; NATARAJ CHANDRASEKARAN [US]; HOWELL JOHN W [US]


Application No.: US20130156828A1  Published: 20/Jun/2013

Title: Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same

Applicant/Assignee:

Application No.: 13/819149   Filing Date: 31/Aug/2011

Abstract:

A drug product comprises a dry powder inhalation device having a pharmaceutical composition present therein, said pharmaceutical composition comprising a compound which is (6alpha, 11beta, 16alpha, 17alpha)-6,9-difluoro-17-{[(fluoromethyl)thio]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1, 4-dien-17-yl 2-furancarboxylate or a solvate thereof

a hygroscopic material, and a package which encompasses the dry powder inhalation device and the hygroscopic material defining an enclosed volume therein, wherein the enclosed volume exhitbits a Relative Humidity of from 20% to 40%.

Priority: US2010-378409P Applic. Date: 2010-08-31; WO2011EP65055 Applic. Date: 2011-08-31

Inventor: ASWANIA OSAMA AHMED [GB]; JIANG ZHONG [GB]; ROCHE TREVOR CHARLES [GB]; WHITAKER MARK [GB]


Application No.: US20130164242A1  Published: 27/Jun/2013

Title: Polymers And Compositions

Applicant/Assignee: LUBRIZOL ADVANCED MATERIALS, INC

Application No.: 13/819875   Filing Date: 01/Sep/2011

Abstract:

The present invention relates to hair care and personal care compositions which contain an acrylic copolymer which is polymerized in the presence of at least two different classes of crosslinking monomers. The polymer functions both as a fixative/film former and a thickening agent for hair styling and personal care compositions in which it is contained. The copolymer exhibits advantageous fixative, film forming and rheological gel properties.

Priority: US2010-379488P Applic. Date: 2010-09-02; WO2011US50196 Applic. Date: 2011-09-01

Inventor: TAMARESELVY KRISHNAN [US]; STAELENS PASCAL [BE]


Application No.: US20130164365A1  Published: 27/Jun/2013

Title: FORMULATIONS FOR TREATMENT WITH GLUCOSINOLATES

Applicant/Assignee:

Application No.: 13/577181   Filing Date: 14/Sep/2011

Abstract:

The application relates to topical formulations comprising a phase II enzyme inducer precursor and an activating agent. Methods for producing and using the topical formulations are also provided.

Priority: US2010-383853P Applic. Date: 2010-09-17; WO2011US51511 Applic. Date: 2011-09-14

Inventor: TALALAY PAUL [US]; FAHEY JED [US]; TALALAY ANTONY [US]


Application No.: US20130164378A1  Published: 27/Jun/2013

Title: Special Prenatal Nutritional Supplement and Design Method Thereof

Applicant/Assignee:

Application No.: 13/820746   Filing Date: 06/Sep/2010

Abstract:

A special prenatal nutritional supplement, characterized as containing active ingredients such as nutrients (including at least one or more vitamins), minerals, or a mixture of pharmaceutical and standard food material. The design method of this special prenatal nutritional supplement is that the type and dosage of the ingredients are defined each day in accordance with the chronological order of the development of the fetus. The product is arranged or displayed like a calendar in a day by day order.

Priority: WO2010CN76633 Applic. Date: 2010-09-06

Inventor: MA ZHONG [US]


Application No.: US20130171203A1  Published: 04/Jul/2013

Title: Composition And Methods For Antimicrobial Articles

Applicant/Assignee:

Application No.: 13/713908   Filing Date: 13/Dec/2012

Abstract:

A biocompatible controlled release form of complexed iodine is achieved by a complexation of polyvinyl alcohol based foam and characterized by a residual starch component to optimize iodine release profiles. The resulting iodine complexed polyvinyl alcohol foam may be utilized locally as an antimicrobial agent that releases controlled amounts of iodine sufficient to kill microbes for extended durations without excessive bulk and rigidity.

Priority: US201161630596P Applic. Date: 2011-12-16

Inventor: ROSENBLATT SOLOMON [US]; KENNEDY JOHN P [US]; JONES CURTIS E [US]


Application No.: US20130195925A1  Published: 01/Aug/2013

Title: ANTI AGING APPLICATION AND METHOD FOR TREATING AGING

Applicant/Assignee: VASKIN, LLC

Application No.: 13/650940   Filing Date: 12/Oct/2012

Abstract:

There is a topical anti-aging composition which is configured to interfere with the production of tyrosinase, as well as melanin by reacting with melanocytes as well as reacting with, or acting on keratinocytes. The anti-aging composition comprises an emulsion comprising a plurality of active ingredients comprising a plurality of pigmentation reducing elements which are configured to interrupt or prevent the production of tyrosinase and melanin. In addition there are a plurality of antioxidants a plurality of anti wrinkling agents a plurality of anti-inflammatory agents at least one additional agent comprising at least one of an emollient, a proactant and a conditioning agent.

Priority: US201161555289P Applic. Date: 2011-11-03

Inventor: ARSHED KHALEEQ Y [US]


Application No.: US20130195927A1  Published: 01/Aug/2013

Title: CERIUM OXIDE NANOPARTICLES AND ASSOCIATED METHODS FOR PROMOTING WOUND HEALING

Applicant/Assignee: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATIONINC, UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION

Application No.: 13/706973   Filing Date: 06/Dec/2012

Abstract:

Novel compositions and methods for the treatment and promotion of wound healing are disclosed herein. There is included a method for treating a wound including administering to a subject in need thereof a wound composition comprising an effective amount of ceria nanoparticles.

Priority: US201161567184P Applic. Date: 2011-12-06

Inventor: SUDIPTA SEAL [US]; DAS SOUMEN [US]


Application No.: US20130202694A1  Published: 08/Aug/2013

Title: Agent for use in the case of fructose intolerance

Applicant/Assignee:

Application No.: 13/833027   Filing Date: 15/Mar/2013

Abstract:

There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed. There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.

Priority: DE20071008664 Applic. Date: 2007-02-20; US2009-544242 Applic. Date: 2009-08-20; WO2008EP01294 Applic. Date: 2008-02-20

Inventor: WYROBNIK DANIEL HENRY [DE]; WYROBNIK ISAAC HARRY [DE]


Application No.: US20130202695A1  Published: 08/Aug/2013

Title: Agent for use in the case of fructose intolerance

Applicant/Assignee:

Application No.: 13/833092   Filing Date: 15/Mar/2013

Abstract:

There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed.

Priority: DE20071008664 Applic. Date: 2007-02-20; US2009-544242 Applic. Date: 2009-08-20; WO2008EP01294 Applic. Date: 2008-02-20

Inventor: WYROBNIK DANIEL HENRY [DE]; WYROBNIK ISAAC HARRY [DE]


Application No.: US20130202696A1  Published: 08/Aug/2013

Title: Agent for use in the case of fructose intolerance

Applicant/Assignee:

Application No.: 13/833160   Filing Date: 15/Mar/2013

Abstract:

There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed.

Priority: DE20071008664 Applic. Date: 2007-02-20; WO2008EP01294 Applic. Date: 2008-02-20; US2009-544242 Applic. Date: 2009-08-20

Inventor: WYROBNIK DANIEL HENRY [DE]; WYROBNIK ISAAC HARRY [DE]


Application No.: US20130216627A1  Published: 22/Aug/2013

Title: Portable Oxygen Enrichment Device and Method of Use

Applicant/Assignee:

Application No.: 13/586223   Filing Date: 15/Aug/2012

Abstract:

Lightweight, small, portable devices and methods are disclosed that provide oxygen-enriched air using an ultra rapid adsorption cycle based on advanced molecular sieve materials.

Priority: US201161527706P Applic. Date: 2011-08-26

Inventor: GALBRAITH STEPHEN DOUGLAS [US]; WALKER DAVID K [US]; MCGOWAN KENNETH J [US]; DEPETRIS ELISE N [US]; GALBRAITH JUDITH C [US]


Application No.: US20130224268A1  Published: 29/Aug/2013

Title: TOPICAL DELIVERY OF HORMONAL AND NON HORMONAL NANO FORMULATIONS, METHODS OF MAKING AND USING THE SAME

Applicant/Assignee: NEWGEN BIOPHARMA CORP

Application No.: 13/778954   Filing Date: 27/Feb/2013

Abstract:

The present invention relates to methods for treating, preventing, minimizing, and/or diminishing signs of aging in the skin comprising topically administering to the subject in need thereof a hormonal nano formulation.

Priority: US201261603814P Applic. Date: 2012-02-27

Inventor: ALAM ABU [US]; JAIKARIA NAVDEEP [US]


Application No.: US20130230569A1  Published: 05/Sep/2013

Title: COMPOSITIONS OF R(+) AND S(-) PRAMIPEXOLE AND METHODS OF USING THE SAME

Applicant/Assignee: KNOPP NEUROSCIENCES, INC

Application No.: 13/862357   Filing Date: 12/Apr/2013

Abstract:

Compositions of predetermined amounts of R(+) pramipexole and S(-) pramipexole and methods of using the same, including for the treatment and prevention of Parkinson's disease, are provided.

Priority: US201113204351 Applic. Date: 2011-08-05; US2007-749497 Applic. Date: 2007-05-16; US2007-733642 Applic. Date: 2007-04-10; US2006-747320P Applic. Date: 2006-05-16; US2006-870009P Applic. Date: 2006-12-14; US2007-894799P Applic. Date: 2007-03-14; US2007-894829P Applic. Date: 2007-03-14; US2007-894835P Applic. Date: 2007-03-14

Inventor: BOZIK MICHAEL E [US]; PETZINGER THOMAS [US]; GRIBKOFF VALENTIN [US]


Application No.: US20130245528A1  Published: 19/Sep/2013

Title: Compositions Comprising Placental Collagen for Use in Wound Healing

Applicant/Assignee:

Application No.: 13/798742   Filing Date: 13/Mar/2013

Abstract:

Provided herein is a topical wound dressing that comprises a collagen and a flexible paste. Also provided is a wound dressing with a first layer of a sterilized mixture of collagen and a second adhesive layer effective to adhere to surrounding skin and to keep the first layer in contact with the wound. In addition there is provided a wound dressing foil that comprises collagen and a plastic compound that can provide a foil shape. Furthermore, methods of dressing wounds utilizing the wound dressings and wound dressing foil are provided herein.

Priority: US201261610570P Applic. Date: 2012-03-14

Inventor: HARRELL CARL RANDALL [US]


Application No.: US20130274372A1  Published: 17/Oct/2013

Title: ANTIMICROBIAL CHEMICAL COMPOSITIONS

Applicant/Assignee: BUNGE AMORPHIC SOLUTIONS LLC

Application No.: 13/448253   Filing Date: 16/Apr/2012

Abstract:

Antimicrobial chemical compositions comprise an aluminum phosphate (AlP) solid dispersed within a binding polymer, wherein one or more bioactive materials are disposed within AlP forming a bioactive-AlP complex. The complex may comprise the bioactive material chemically bonded with the AlP, physically combined with the AlP, or a combination of both. The complex may be formed according to precipitation, condensation and sol-gel methods of forming. The complex is engineered to provide a controlled delivery of the bioactive material or a constituent thereof upon exposure to moisture to give a desired level of antimicrobial resistance to a film or composite formed from the composition of at least about 30 mug/m2, and may also provide a desired degree of corrosion resistance through the release of passivating phosphate anion. Such antimicrobial chemical compositions provide an improved degree of active, long-term resistance to a broad range of micro-organisms when compared to known antimicrobial chemical compositions.

Priority:

Inventor: FOSCANTE RAYMOND E [US]


Application No.: US20130280189A1  Published: 24/Oct/2013

Title: PERSONAL CARE AND HEALTH CARE COMPOSITIONS

Applicant/Assignee: DOW CORNING FRANCE SAS, DOW CORNING CORPORATION

Application No.: 13/994864   Filing Date: 09/Jan/2012

Abstract:

The present invention relates to topical compositions comprising a non adhesive film forming silicone acrylate hybrid composition, at least one physiologically acceptable ingredient and at least one physiologically acceptable solvent. Such non adhesive film forming silicone acrylate hybrid compositions tend to provide comfortable films for topical compositions.

Priority: US201161431165P Applic. Date: 2011-01-10; WO2012IB00249 Applic. Date: 2012-01-09

Inventor: THOMAS XAVIER JEAN-PAUL [FR]; MITCHELL TIMOTHY [US]


Application No.: US20130280308A1  Published: 24/Oct/2013

Title: PHARMACEUTICAL COMPOSITIONS OF ANTI-ACNE AGENTS

Applicant/Assignee: CADILA HEALTHCARE LIMITED

Application No.: 13/880187   Filing Date: 19/Oct/2011

Abstract:

The present invention relates to pharmaceutical compositions for treatment of acne. In particular, the present invention relates to stable pharmaceutical compositions for treatment of acne along with other pharmaceutically acceptable excipients. These compositions exhibit excellent stability, greater permeability, and enhanced therapeutic efficacy. The invention also relates to processes for the preparation of such compositions.

Priority: IN2010MU02935 Applic. Date: 2010-10-21; IN2011MU02153 Applic. Date: 2011-07-28; WO2011IN00723 Applic. Date: 2011-10-19

Inventor: ROY SUNILENDU BHUSHAN [IN]; KOTHARI JAY SHANTILAL [IN]; SHEIKH SHAFIQ [IN]; PANCHOLI JINESH SURESH [IN]; PATEL JITENDRA DASHARATHLAL [IN]; MITTAL RAVINDRA [IN]


Application No.: US20130287837A1  Published: 31/Oct/2013

Title: SOLID DRESSING FOR TREATING WOUNDED TISSUE

Applicant/Assignee:

Application No.: 13/843604   Filing Date: 15/Mar/2013

Abstract:

Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.

Priority: US2007-882872 Applic. Date: 2007-08-06; US2006-835423P Applic. Date: 2006-08-04

Inventor: MACPHEE MARTIN [US]; BEALL DAWSON [US]


Application No.: US20130295038A1  Published: 07/Nov/2013

Title: Cross-Linked Copolymer Containing Phosphorylcholine Monomer and Cosmetic Composition Containing Same

Applicant/Assignee: KCI LIMITED

Application No.: 13/978625   Filing Date: 23/Nov/2011

Abstract:

Disclosed is a copolymer containing an alpha,beta-ethylenically unsaturated monomer, a phosphorylcholine monomer, and a cross-linking agent as a monomer. Also disclosed are a cosmetic composition containing the copolymer and a cosmetic material using the cosmetic composition.

Priority: KR20110001978 Applic. Date: 2011-01-07; KR20110122960 Applic. Date: 2011-11-23; WO2011KR08989 Applic. Date: 2011-11-23

Inventor: KIM YONG CHUL [KR]; KIM HYEONG BAE [KR]; HAN IN SUN [KR]; WANG SE KWAN [KR]; PARK JUNG HO [KR]


Application No.: US20130295145A1  Published: 07/Nov/2013

Title: TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING ETODOLAC

Applicant/Assignee: CADILA HEALTHCARE LIMITED

Application No.: 13/880302   Filing Date: 18/Oct/2011

Abstract:

The present invention relates to stable pharmaceutical compositions comprising nano size droplets of etodolac or salts thereof along with other pharmaceutically acceptable excipients. These compositions exhibit greater permeability, and improved bioavailability leading to enhanced therapeutic activity. The invention also relates to processes for the preparation of such compositions.

Priority: IN2010MU02925 Applic. Date: 2010-10-21; WO2011IN00717 Applic. Date: 2011-10-18

Inventor: ROY SUNILENDU BHUSHAN [IN]; KOTHARI JAY SHANTILAL [IN]; SHEIKH SHAFIQ [IN]; PATEL JITENDRA DASHARATHLAL [IN]; PANCHOLI JINESH SURESH [IN]


Application No.: US20130295151A2  Published: 07/Nov/2013

Title: PROCESS FOR THE TREATMENT OF CELLULOSIC MOLDED BODIES

Applicant/Assignee: LENZING AKTIENGESELLSCHAFT

Application No.: 13/119807   Filing Date: 27/Aug/2009

Abstract:

The present invention relates to a process for the treatment of a cellulosic molded body, wherein the molded body is contacted with an acid solution of a chitosan. The process according to the invention is characterized in that the chitosan has a deacetylation degree of at least 80%, a nitrogen content of at least 7 w %, preferably at least 7.5 w %, a weight average molecular weight Mw (D) of 10 kDa to 1000 kDa, preferably 10 kDa to 160 kDa, and a viscosity in 1 w % solution in 1 w % acetic acid at 25 DEG C. of 1000 mPas or less, preferably 400 mPas or less, in particular preferably 200 mPas or less.

Priority: AT20080001471 Applic. Date: 2008-09-22; WO2009AT00334 Applic. Date: 2009-08-27

Inventor: REDLINGER SIGRID [AT]; RICHARDT WERNER [AT]; FIRGO HEINRICH [AT]


Application No.: US20130309216A1  Published: 21/Nov/2013

Title: DIETARY SUPPLEMENT ENHANCING THE MUSCULAR ENERGY METABOLISM, COMPRISING AN ALKANOYL CARNITINE AND RIBOSE

Applicant/Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A

Application No.: 13/952083   Filing Date: 26/Jul/2013

Abstract:

A method for treating myocardial or skeletal muscle anoxia which occurs in coronary or post-infarct disorders or during prolonged physical activity and muscle fatigue. This method comprises the administration of a combination composition comprising (a) an alkanoyl L-carnitine selected from the group consisting of isovaleryl L-carnitine, propionyl L-carnitine or the pharmacologically acceptable salts thereof or mixtures thereof

and (b) ribose or a phosphate derivative thereof.

Priority: IT2000RM00323 Applic. Date: 2000-06-14; US2010-753368 Applic. Date: 2010-04-02; US2006-604390 Applic. Date: 2006-11-27; US2002-048590 Applic. Date: 2002-02-01; WO2001IT00283 Applic. Date: 2001-06-01

Inventor: PIETRO POLA [IT]


Application No.: US20130309274A1  Published: 21/Nov/2013

Title: WOUND DEBRIDEMENT

Applicant/Assignee: THE CURATORS OF THE UNIVERSITY OF MISSOURI

Application No.: 13/475232   Filing Date: 18/May/2012

Abstract:

A method for debridement of wound on the skin by placing against the wound a glass-based borate-based composition to release dissolution products which support neutrophilic activity into the wound by dissolution.

Priority:

Inventor: JUNG STEVEN B [US]


Application No.: US20130337016A1  Published: 19/Dec/2013

Title: METHOD FOR TREATMENT OF ACNE USING PHARMACEUTICAL COMPOSITIONS OF CLINDAMYCIN AND ADAPALENE

Applicant/Assignee: CADILA HEALTHCARE LIMITED

Application No.: 13/880092   Filing Date: 19/Oct/2011

Abstract:

The present invention relates to a method for treating, reducing or preventing acne. In particular, the present invention relates to methods for reducing the total number, incidence and severity of acne lesions on the skin which includes both inflammatory and non-inflammatory lesions. Further, the invention relates to reducing the incidence and severity of adverse events resulting from topical application of anti-acne agents resulting in improvement of skin tone. The method includes administering a novel and stable topical anti-acne pharmaceutical composition.

Priority: IN2010MU02935 Applic. Date: 2010-10-21; IN2011MU02154 Applic. Date: 2011-07-28; WO2011IN00724 Applic. Date: 2011-10-19

Inventor: MITTAL RAVINDRA [IN]; ROY SUNILENDU BHUSHAN [IN]; KOTHARI JAY SHANTILAL [IN]; SHEIKH SHAFIQ [IN]; PATEL JITENDRA DASHARATHLAL [IN]; PANCHOLI JINESH SURESH [IN]


Application No.: US20130344164A1  Published: 26/Dec/2013

Title: PERSONAL CARE PRODUCTS CONTAINING RAINWATER

Applicant/Assignee: P.V. CREATIONS

Application No.: 14/015188   Filing Date: 30/Aug/2013

Abstract:

This invention relates generally to formulations and methods for improving level of moisture absorption and retention by the skin and for improving the appearance, feel, or comfort of the skin, wherein the formulations comprise pure rainwater. In another embodiment of the invention, the formulations comprise a combination of natural extracts. The present invention is a formulation made substantially without the use of synthetic chemicals and petroleum by-products, wherein the formulation is used for personal care. More specifically, the present invention is a skin care product formulation wherein 90% or more of the ingredients are natural products.

Priority: US201113059578 Applic. Date: 2011-02-17; WO2009US54784 Applic. Date: 2009-08-24; US2008-090969P Applic. Date: 2008-08-22

Inventor: VILINSKY PNINA [US]

   
US Applications Published in 2012
...or use our Search Engine to
search for patent documents by
number.
Search for anything. Simply
type the words in the box..
Clck to enlarge and view details